JNJ-86974680 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 2

Top Sponsors

Johnson & Johnson Enterprise Innovation Inc.1
Janssen Research & Development, LLC1

Indications

Cancer2
Prostatic Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Lung Cancer1

Sarasota, Florida1 trial

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

Florida Cancer Specialists

Phase 1

Newnan, Georgia1 trial

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

City of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.